Altamira Therapeutics Ltd (NASDAQ:CYTO) Stock Price Slipped -8.86% to $1.44
Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is an average of — analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0. According to 1 analyst […]
A leader in the success game: Altamira Therapeutics Ltd (CYTO) Stock
Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2022) is $0. This is an average of 0 analysts’ earnings, where the high earnings per share estimate is $0 and the low earnings per share estimate is $0. According to 1 analyst […]
